Abiomed Recovering Hearts. Saving Lives
Our Company Investors News Products Clinicians Patients & Families Customer Service

Clinical Presentations
Clinical Updates
Case Studies
Published Papers
Conventions
Glossary
 
Patient on ABIOMED BVS LVAD Receives Heart Transplant
A 31-year-old male was admitted to a local community hospital emergency room with chest pain. He was taken to the cardiac catheterization laboratory where a stent was placed. The patient was treated with aspirin, Plavix and Reopro. An echocardiogram was and chest x ray were performed. The patient was diagnosed with heart failure and discharged to home. Two weeks later, the patient was readmitted to the emergency room with chest pain. He was taken to the cardiac catheterization laboratory where 100% occlusion of the previously placed stent was diagnosed. Immediately after diagnosis, the patient had cardiac arrest and was taken to the operating room for coronary artery bypass. In addition to the bypass surgery, the patient had an ABIOMED BVS5000 LVAD implanted. The patient was then transported via helicopter to a regional heart transplant center. The decision was then made to transition the patient to a longer term ventricular assist device and place the patient on the waiting list for a heart transplant. Two months later the patient received a heart transplant.

History
A 31-year-old male was admitted to a local communty hospital emergency room with substernal chest pain. He was taken to the catheterization laboratory.where a stent was placed in the LAD. The patient was treated with aspirin, Plavix and Reopro. a an anterior apical hypokinesis with possible apical thrombus and moderate mital regurgitation. Chest x-ray was consistent with congestive heart failure. The patient was discharged home. Two weeks later, the patient was readmitted to the emergency room with chest pain. He was taken to the catheterization laboratory where 100% occulsion of the stent was diagnosed. Immediately after diagnosis, the patient arrested, CPR initiated, and was the patient was taken to the OR.

Operative Summary
Coronary artery bypass graft x 3 involving the saphenous vein to the obtuse marginal one, obtuse marginal two and the left anterior descending arteries were performed. Unable to wean from CPB, the Abiomed LVAD was implanted with assisted C.O of 5.5 L/minute. A 36 Fr. atria cannula was implanted into the right superior pulmonary vein with a 12mm arterial cannula anastomosed to the ascending aorta.

Post-operative Summary
On POD 1, the patient was transported via helicopter to a regional transplant center for further evaluation. Upon arrival, an echocardiogram revealed a large laminated thrombus, at least 50% of the left ventricle was found to be severe with an EF of 5%, a severe right ventricle and a PFO. Due to the patient's severity, he was immediately staged to a long-term implantable LVAS with repair of the PFO. His postoperative course was complicated by bleeding requiring a return to the operating room for clot removal, VF requiring DCC, amiodarone for treatment for AF, respiratory distress requiring prolonged intubation, and thrombocytopenia. Two months later the patient was taken to the O.R for removal of the LVAS and OHT with bicaval anastomosis. The post OHT course was uncomplicated.

Patient Data
Indication: Post-cardiotomy cardiogenic shock
Type of Support: LVAD
Age: 31 Gender: M Wt: 82.4 kg Ht: 191 cm BSA: 2.11 m2

Surgical Data
Procedure: CABG x 3
Total CPB time: 6 hours 46 minutes
Attempts to wean off CPB: 2
Time between second CPB and LVAD: 35 minutes
IABP prior to LVAD: Yes
Cannulation sites: Right SPV 36 Fr. atrial; Ascending Aorta 12mm arterial

Patient Hemodynamics

Pre BVS Implant On BVS Support BVS Explanted
MAP: 92 84 85
CVP: 22 17 3
PAP: 58/36 20/12 21/13
CO Not obtained 5.5 6.1
CI Not obtained 2.5 2.9
EF% 5 5 Normal

 

 

 

 

 

Inotropic Support

Pre BVS Implant On BVS Support BVS Explanted
Dopamine mcg/kg/min 5 Off Off
Nitroglycerine mcg/min
66 Off Off
Dobutamine mcg/kg/min
Off 4.5 Off
Milrinone mcg/kg/min
0.5 Off Off

 

 

 


Organ Function

Pre BVS Implant On BVS Support BVS Explanted
Liver:
     
AST U/m
Not obtained 192 14
ALT U/ml
Not obtained 44 17
Kidney:
     
BUN mg/dl
15 15 8
Creatinine mg/dl
1.1 0.9 1.2


 

 

 

 

 

Anticoagulation Therapy
Titrated Heparin Initiation time: 6 hours 30 minutes post BVS LVAD implant
Average chest tube drainage upon heparin initiation: 40 cc
ACT range: 136 &8211; 197 seconds